Patent holdings for IPC class A61K 31/165

Total number of patents in this class: 3632

10-year publication summary

277
273
289
318
302
283
233
245
202
59
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
The Regents of the University of California
20587
50
Newron Pharmaceuticals S.p.A.
61
40
Novartis AG
10341
28
Les Laboratoires Servier
500
27
LTS Lohmann Therapie-Systeme AG
685
25
Murray and Poole Enterprises Limited
28
25
Allergan, Inc.
2204
20
The General Hospital Corporation
4832
20
Axsome Malta Ltd.
78
20
President and Fellows of Harvard College
6055
17
BIAL - Portela & CA, S.A.
214
17
Indiana University Research and Technology Corporation
785
17
Dana-Farber Cancer Institute, Inc.
2654
16
Vanda Pharmaceuticals, Inc.
382
16
Board of Regents, The University of Texas System
6062
15
Brightseed, Inc.
59
15
Children's Medical Center Corporation
1933
14
The United States of America, as represented by the Secretary, Department of Health and Human Services
2976
14
Jazz Pharmaceuticals Research UK Limited
253
14
The Trustees of the University of Pennsylvania
4406
13
Other owners 3209